Core Viewpoint - 瑞丽医美 has entered into a subscription agreement to acquire shares in 莱丽医美有限公司, which will enhance its business operations in Hong Kong and provide potential investment returns [1][2] Group 1: Subscription Agreement Details - 瑞丽医美 will issue a total of 170,000 shares to the first investor 瑞丽美学有限公司 at a subscription price of 2.55 million HKD and 63,300 shares to the second investor 比夫有限公司 at a subscription price of 950,000 HKD [1] - After the completion of the agreement, the shareholding will be distributed as follows: 缪诗美学 will hold 30.0%, the first investor will hold 51.0%, and the second investor will hold 19.0% of the target company [1] - The target company 莱丽医美有限公司 will become an indirect non-wholly owned subsidiary of 瑞丽医美, and its financial performance will be consolidated into the group’s accounts post-completion [1] Group 2: Strategic Rationale - The board believes that the subscription aligns with the group’s business expansion strategy, particularly in enhancing its presence in the Hong Kong market [2] - The subscription is viewed as a unique opportunity to promote the brand and provide beauty services to potential customers, creating synergies with existing operations [2] - The operational and financial performance of the target company is expected to improve once it commences beauty services in Hong Kong, potentially leading to investment returns for the group [2]
瑞丽医美(02135)附属拟255万港元认购莱丽医美51.0%股权